Nivagen Pharmaceuticals, Inc.
Govind Jagadale has been working in the pharmaceutical industry since 2007, starting as an Officer at Cipla. With a Bachelor's degree in Chemistry from Shivaji University, followed by a Master's degree in organic chemistry, Govind has held various positions such as Executive at Piramal Enterprises Limited, SRA at Ajanta Pharma Ltd where Govind served as a Group Leader for new generic products. Govind then moved on to UMEDICA LABS as an Assistant Manager, focusing on ADL ANDA. Transitioning to Glenmark Pharmaceuticals Ltd as an SRO, and currently as a Sr. Chemist at Nivagen Pharmaceuticals, Inc., Govind brings a wealth of experience and expertise in the pharmaceutical sector.
Nivagen Pharmaceuticals, Inc.
Nivagen is engaged in the development, acquisition, and sales of generic prescription drugs and over the counter products for the North American market. It envisions to deliver high-quality products at affordable prices by leveraging global partnerships with the best FDA approved manufacturing facilities across the world.The US genericprescription market is currently at approximately $60 billion, and over $120 billion's worth of products will be coming off of patent protection in the next 10 years. Nivagen believes that, with its strategic partnership model of global alliances with highly efficient pharmaceutical companies across the globe, they can provide cost savings to the consumer while creating value for all members of the supply chain.